熱門資訊> 正文
2024-03-26 04:29
Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $(0.56) by 76.79 percent. This is a 16.1 percent increase over losses of $(1.18) per share from the same period last year.